Kardigan Insider Trades
NASDAQ: KARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $90.00M
- Sales
- 0 · $0
- Shares bought / sold
- 5.63M / 0
- Net activity
- Net buying $90.0 million
Kardigan insider activity
Over the last 12 months, Kardigan insiders reported 23 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $90.0 million and sold $0 worth of stock, for net insider buying of $90.0 million. The most recent filing shows HRTG GPE, LLC & HRTG PV, L.P. & HRTG CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon (10% Owner) buying 3,125,000 shares at $16.00 on Jun 22, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KARD's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
KARD insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 22, 2026 | ARCH Venture Partners XIII, LLC & ARCH Venture Partners XIII, L.P. & ARCH Venture Fund XIII, L.P. & CRANDELL KEITH & NELSEN ROBERT & Burow Kristina & GILLIS STEVENDirector | Buy | 1,250,000 | $20.00M | Form 4 |
| Jun 22, 2026 | BERNS PAUL LDirector | Buy | 1,250,000 | $20.00M | Form 4 |
| Jun 22, 2026 | HRTG GPE, LLC & HRTG PV, L.P. & HRTG CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% Owner | Buy | 3,125,000 | $50.00M | Form 4 |
| Jun 17, 2026 | Edelberg JayChief Medical Officer | Award | 47,784 | — | Form 4 |
| Jun 17, 2026 | Edelberg JayChief Medical Officer | Conversion | 97,587 | — | Form 4 |
| Jun 17, 2026 | Giordano Douglas E.Director | Award | 20,706 | — | Form 4 |
| Jun 17, 2026 | GIANAKAKOS ANASTASIOSPresident & CEO | Conversion | 498,692 | — | Form 4 |
| Jun 17, 2026 | GIANAKAKOS ANASTASIOSPresident & CEO | Conversion | 41,001 | — | Form 4 |
| Jun 17, 2026 | GIANAKAKOS ANASTASIOSPresident & CEO | Conversion | 28,702 | — | Form 4 |
| Jun 17, 2026 | Walbert Timothy PDirector | Award | 20,706 | — | Form 4 |
| Jun 17, 2026 | Moriarty John BChief Legal Officer | Award | 47,784 | — | Form 4 |
| Jun 17, 2026 | BERNS PAUL LDirector | Award | 20,706 | — | Form 4 |
| Jun 17, 2026 | BERNS PAUL LDirector | Conversion | 13,792,035 | — | Form 4 |
| Jun 17, 2026 | ARCH Venture Partners XIII, LLC & ARCH Venture Partners XIII, L.P. & ARCH Venture Fund XIII, L.P. & CRANDELL KEITH & NELSEN ROBERT & Burow Kristina & GILLIS STEVENDirector | Conversion | 13,792,035 | — | Form 4 |
| Jun 17, 2026 | Popovits Kimberly JDirector | Award | 20,706 | — | Form 4 |
| Jun 17, 2026 | Jahn BrianneChief Financial Officer | Award | 79,640 | — | Form 4 |
| Jun 17, 2026 | HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% Owner | Conversion | 2,348,373 | — | Form 4 |
| Jun 17, 2026 | HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% Owner | Conversion | 3,242,993 | — | Form 4 |
| Jun 17, 2026 | HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% Owner | Conversion | 6,150,502 | — | Form 4 |
| Jun 17, 2026 | HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% Owner | Conversion | 2,050,166 | — | Form 4 |
| Jun 17, 2026 | Meeker David PDirector | Award | 20,706 | — | Form 4 |
| Jun 17, 2026 | Pasternak AndyChief Strategy Officer | Award | 79,640 | — | Form 4 |
| Jun 17, 2026 | PERCEPTIVE ADVISORS LLC & PERCEPTIVE LIFE SCIENCES MASTER FUND LTD & Perceptive Capital Solutions Holdings LP & EDELMAN JOSEPHDirector | Award | 20,706 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4